Literature DB >> 11716327

Spontaneous echo contrast in descending aorta correlates with low blood-flow velocity in carotid arteries and hemostatic abnormalities.

O Yamamura1, Y Miyoshi, S Hiraki, H Ono, H Ootaki, J Fujiyama, M Kuriyama.   

Abstract

Spontaneous echo contrast in the descending aorta (DA-SEC) was examined as a possible risk factor for cerebral thromboembolism. In 19 patients (10 males, 9 females) in the chronic stage of cerebral infarction, abnormal findings by transesophageal echocardiography, flow dynamics of the common carotid artery (CCA), and hemostatic factors including blood coagulation and fibrinolysis were investigated. In nine patients, DA-SEC was detected, and SEC in left atrium (LA-SEC) was detected in nine patients. The DA-SEC positive group showed decreased blood-flow velocity (BFV) in bilateral CCA, high levels of thrombin-antithrombin III complex (TAT) and prothrombin fragment 1.2 (F1+2), a decrease in platelet count and a slight increase in D-dimer, which means an activated state of thrombin generation and resulting fibrinolysis, compared to the DA-SEC negative group. On the other hand, the LA-SEC positive group showed normal BFV in CCA and only a slight increase in D-dimer. We conclude that the condition producing DA-SEC is a stronger risk factor for cerebral infarction than that producing LA-SEC.

Entities:  

Mesh:

Year:  2001        PMID: 11716327     DOI: 10.1177/000331970105201104

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  2 in total

1.  Relationship between spontaneous echo contrast in the thoracic aorta and plasma von Willebrand factor.

Authors:  Takuya Inoue; Makoto Suzuki; Atsushi Namiki; Hironori Hirai; Kaoru Sugi
Journal:  J Med Ultrason (2001)       Date:  2006-12-22       Impact factor: 1.314

Review 2.  Plasma fibrin D-dimer and the risk of left atrial thrombus: A systematic review and meta-analysis.

Authors:  Huaibin Wan; Shuang Wu; Yanmin Yang; Jun Zhu; Aidong Zhang; Yan Liang
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.